That increase in (clinical) revenue wasn't matched by profit in the half yearly report though was it?
Is gross margin worked out as 65% to the doctor then 35% to DOD? And just wondering if anyone has done the math from the half yearly report or has information on what percent of the gross profit will come through to shareholders? Thank you
- Forums
- ASX - By Stock
- VIT
- Ann: First supply of Psilocybin
Ann: First supply of Psilocybin, page-14
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VIT (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.46M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 6.9¢ | $40.9K | 591.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 153567 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 28912 | 0.069 |
3 | 75000 | 0.068 |
1 | 10000 | 0.067 |
3 | 142118 | 0.065 |
1 | 16000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 153567 | 2 |
0.081 | 100000 | 1 |
0.092 | 66999 | 1 |
0.094 | 1300 | 1 |
0.095 | 9017 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
VIT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online